NanoGroup S.A. (WSE: NNG)
Poland
· Delayed Price · Currency is PLN 4.060
+0.120 (3.05%)
Sep 27, 2024, 5:00 PM CET
NanoGroup Revenue
NanoGroup had revenue of 2.00K PLN in the quarter ending March 31, 2024, a decrease of -93.10%. This brings the company's revenue in the last twelve months to -24.98K, down -120.06% year-over-year. In the year 2023, NanoGroup had annual revenue of 2.02K, down -98.55%.
Revenue (ttm)
-24.98K
Revenue Growth
-120.06%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
98.34M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 2.02K | -137.53K | -98.55% |
| Dec 31, 2022 | 139.55K | -352.94K | -71.66% |
| Dec 31, 2021 | 492.49K | -195.02K | -28.37% |
| Dec 31, 2020 | 687.51K | 169.78K | 32.79% |
| Dec 31, 2019 | 517.73K | 206.93K | 66.58% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Oct 29, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Krka, d. d. | 8.06B |
| NEUCA S.A. | 12.13B |
| Sopharma AD | 4.35B |
| Synektik Spólka Akcyjna | 618.67M |
| Celon Pharma S.A. | 206.81M |
| Ryvu Therapeutics S.A. | 82.39M |
| Voxel S.A. | 476.19M |
| Selvita S.A. | 329.02M |